HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $52,917,000 | +19.8% | 2,002,195 | -11.4% | 0.24% | +11.2% |
| Q4 2018 | $44,154,000 | -8.0% | 2,259,727 | -7.8% | 0.22% | +12.0% |
| Q3 2018 | $48,004,000 | -11.6% | 2,451,701 | -25.3% | 0.19% | -20.0% |
| Q2 2018 | $54,325,000 | +2.2% | 3,280,467 | -9.9% | 0.24% | +8.6% |
| Q1 2018 | $53,130,000 | 0.0% | 3,639,173 | 0.0% | 0.22% | 0.0% |
| Q4 2017 | $53,130,000 | +5.9% | 3,639,173 | -8.0% | 0.22% | +0.5% |
| Q3 2017 | $50,173,000 | +185.3% | 3,956,981 | +231.6% | 0.22% | +161.9% |
| Q2 2017 | $17,586,000 | 0.0% | 1,193,420 | 0.0% | 0.08% | 0.0% |
| Q1 2017 | $17,586,000 | -4.7% | 1,193,420 | +4.6% | 0.08% | -16.0% |
| Q4 2016 | $18,452,000 | -50.4% | 1,140,538 | -44.4% | 0.10% | -52.2% |
| Q3 2016 | $37,169,000 | +97.3% | 2,050,199 | +278.1% | 0.21% | +53.7% |
| Q2 2015 | $18,838,000 | -31.2% | 542,278 | -48.6% | 0.14% | -32.0% |
| Q1 2015 | $27,375,000 | – | 1,054,141 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |